Subversion and utilization of the host cell cyclic adenosine 5′-monophosphate/protein kinase a pathway by Brucella during macrophage infection

被引:41
作者
Gross, A
Bouaboula, M
Casellas, P
Liautard, JP
Dornand, J
机构
[1] Univ Montpellier 2, INSERM U431, IFR 56, F-34095 Montpellier, France
[2] Sanofi Rech, F-34082 Montpellier, France
关键词
D O I
10.4049/jimmunol.170.11.5607
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Brucella spp. are intramacrophage pathogens that induce chronic infections, in a wide range of mammals, including domestic animals and humans. Therefore, the macrophage response to infection has important consequences for both the survival of phagocytosed bacteria and the further development of host immunity. However, very little is known about the macrophage cell signaling pathways initiated upon infection and the virulence strategy that Brucella use to counteract these responses and secure their survival. In a previous study, we have shown that macrophages activated by SR141716A, a ligand of the cannabinoid receptor CB1, acquired the capacity to control Brucella and observed that the CB1 receptor-triggering engages the microbicidal activity of phagocytes. To analyze the perturbation of cell signaling pathway during macrophage infection by Brucella, we hypothesized that SR141716A provides cell signaling that interferes with the bacterial message leading to inhibition of macrophage functions. As CB1 receptor belongs to the family of G protein-linked receptors, we explored the cAMP signaling pathway. In this study, we show that the CB1 ligand inhibited the bacteria-induced cell signaling. Taking advantage of this result, we then demonstrated that Brucella infection elicited a rapid activation of the cAMP/protein kinase A pathway. This activation resulted in a prolonged phosphorylation of the transcription factor CREB. We finally demonstrate that the activation of the cAMP/protein kinase A pathway is crucial for the survival and establishment of Brucella within macrophages. For the first time in phagocytes, we thus characterized a primordial virulence strategy of Brucella involving the host signaling pathway, a novel point of immune intervention of this virulent pathogen.
引用
收藏
页码:5607 / 5614
页数:8
相关论文
共 53 条
[1]   A phagosome of one's own: a microbial guide to life in the macrophage [J].
Amer, AO ;
Swanson, MS .
CURRENT OPINION IN MICROBIOLOGY, 2002, 5 (01) :56-61
[2]   Intracellular trafficking of Brucella abortus in J774 macrophages [J].
Arenas, GN ;
Staskevich, AS ;
Aballay, A ;
Mayorga, LS .
INFECTION AND IMMUNITY, 2000, 68 (07) :4255-4263
[3]  
Baldwin C L, 1994, Immunol Ser, V60, P363
[4]   The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo [J].
Beshay, E ;
Croze, F ;
Prud'homme, GJ .
CLINICAL IMMUNOLOGY, 2001, 98 (02) :272-279
[5]   p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells -: Roles of nuclear factors, nuclear factor κB, cAMP response element-binding protein, ccaat/enhancer-binding protein-β, and activating transcription factor-2 [J].
Bhat, NR ;
Feinstein, DL ;
Shen, Q ;
Bhat, AN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (33) :29584-29592
[6]   The Brucella suis virB operon is induced intracellularly in macrophages [J].
Boschiroli, ML ;
Ouahrani-Bettache, S ;
Foulongne, V ;
Michaux-Charachon, S ;
Bourg, G ;
Allardet-Servent, A ;
Cazevieille, C ;
Liautard, JP ;
Ramuz, M ;
O'Callaghan, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (03) :1544-1549
[7]  
Burzyn D, 2002, J LEUKOCYTE BIOL, V72, P93
[8]   MECHANISMS OF BINDING OF BRUCELLA-ABORTUS TO MONONUCLEAR PHAGOCYTES FROM COWS NATURALLY RESISTANT OR SUSCEPTIBLE TO BRUCELLOSIS [J].
CAMPBELL, GA ;
ADAMS, LG ;
SOWA, BA .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 41 (3-4) :295-306
[9]   RELEASE OF 5'-GUANOSINE MONOPHOSPHATE AND ADENINE BY BRUCELLA-ABORTUS AND THEIR ROLE IN THE INTRACELLULAR SURVIVAL OF THE BACTERIA [J].
CANNING, PC ;
ROTH, JA ;
DEYOE, BL .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (03) :464-470
[10]  
Caron E, 1996, J IMMUNOL, V156, P2885